Closer to the Reality-Proteome Changes Evoked by Endometrial Scratching in Fertile Females.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Sep 2023
Historique:
received: 14 07 2023
revised: 22 08 2023
accepted: 29 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Endometrial scratching (ES) has been widely used in assisted reproductive technology to possibly improve pregnancy rates, but its exact mechanism is still not understood or investigated, and its benefits are controversially discussed. Hypothetically, ES may trigger a local immune response, leading to an improved endometrial receptivity. So far, it has been shown that ES affects the gene expression of cytokines, growth factors, and adhesive proteins, potentially modulating inflammatory pathways and adhesion molecule expression. Our pilot study applying proteomic analysis reveals that ES probably has an impact on the proteins involved in immune response pathways and cytoskeleton formation, which could potentially increase endometrial receptivity. Specifically, proteins that are involved in the immune response and cytoskeleton regulation showed a trend toward higher abundance after the first ES. On the other hand, proteins with a decreasing abundance after the first ES play roles in the regulation of the actin cytoskeleton and cellular processes such as intracellular transport, apoptosis, and autophagy. These trends in protein changes suggest that ES may affect endometrial tissue stiffness and extracellular matrix remodeling, potentially enhancing the embryos' implantation. To our knowledge, this pilot study provides, for the first time, data investigating potential changes in the endometrium due to the scratching procedure that might explain its possible benefit for patients in infertility treatment. Furthermore, the proteome of a group of patients suffering from repeated implantation failure was compared to that of the fertile group in order to transfer the basic science to clinical routine and application.

Identifiants

pubmed: 37686380
pii: ijms241713577
doi: 10.3390/ijms241713577
pmc: PMC10488085
pii:
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : ARB HE3544/S-1

Références

Mol Cancer Res. 2019 Feb;17(2):370-383
pubmed: 30322860
Fertil Steril. 2020 May;113(5):1050-1066.e7
pubmed: 32386616
Nucleic Acids Res. 2014;42(17):10873-87
pubmed: 25183524
Elife. 2019 Apr 25;8:
pubmed: 31021318
Nature. 2013 Jun 13;498(7453):241-5
pubmed: 23739326
Immunol Rev. 2023 Mar;314(1):158-180
pubmed: 36440666
Biomolecules. 2022 Aug 31;12(9):
pubmed: 36139050
Meta Gene. 2014 May 15;2:366-73
pubmed: 25606421
Reprod Biomed Online. 2013 Nov;27(5):486-96
pubmed: 23933033
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
pubmed: 11309499
Int J Mol Sci. 2019 Dec 18;21(1):
pubmed: 31861484
Nat Commun. 2015 Sep 10;6:8218
pubmed: 26356418
Reprod Sci. 2023 Jun;30(6):1701-1711
pubmed: 36471216
Arch Gynecol Obstet. 2022 Nov;306(5):1761-1769
pubmed: 35987819
Biol Reprod. 1972 Aug;7(1):82-6
pubmed: 5050152
Mol Hum Reprod. 2000 May;6(5):469-73
pubmed: 10775652
Mol Ther. 2020 Nov 4;28(11):2458-2472
pubmed: 32592690
Biol Reprod. 2021 Jan 4;104(1):11-26
pubmed: 32856701
Fertil Steril. 2003 Jun;79(6):1317-22
pubmed: 12798877
Biochem Pharmacol. 2016 Dec 15;122:80-89
pubmed: 27751820
Oncotarget. 2019 Apr 23;10(30):2899-2910
pubmed: 31080560
J Hum Reprod Sci. 2012 Jan;5(1):2-6
pubmed: 22870007
Fertil Steril. 2010 Nov;94(6):2030-6
pubmed: 20338560
Medicine (Baltimore). 2020 Mar;99(13):e19665
pubmed: 32221094
Reprod Biomed Online. 2012 Dec;25(6):561-71
pubmed: 23063812
Reprod Biomed Online. 2013 Nov;27(5):530-8
pubmed: 23933035
Oncogene. 2009 Apr 16;28(15):1748-58
pubmed: 19270727
Bull Math Biol. 2021 Feb 17;83(4):26
pubmed: 33594536
Hum Reprod. 2014 Dec;29(12):2855-6
pubmed: 25316455
BMC Bioinformatics. 2012;13 Suppl 16:S12
pubmed: 23176165
Hum Reprod. 2014 Sep;29(9):1957-67
pubmed: 25106620
J Proteome Res. 2014 May 2;13(5):2339-51
pubmed: 24646099
Cancers (Basel). 2023 Jan 12;15(2):
pubmed: 36672435
Front Cell Dev Biol. 2021 Mar 16;9:613277
pubmed: 33796523
Nat Commun. 2019 May 8;10(1):2110
pubmed: 31068593
Am J Reprod Immunol. 2010 Jan;63(1):17-21
pubmed: 20059465
J Reprod Immunol. 2015 Apr;108:114-22
pubmed: 25779030
Development. 2007 Sep;134(18):3239-49
pubmed: 17720693
Hum Reprod. 2014 Nov;29(11):2474-81
pubmed: 25205759
Commun Biol. 2020 Oct 27;3(1):620
pubmed: 33110168
Reprod Med Biol. 2018 Feb 01;17(3):220-227
pubmed: 30013421
EPMA J. 2022 May 21;13(2):237-260
pubmed: 35719135
Gynecol Endocrinol. 2015 Apr;31(4):313-6
pubmed: 25561347
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009517
pubmed: 22786529
Mol Cell Biol. 2000 Sep;20(17):6224-32
pubmed: 10938099
Science. 2003 Jan 10;299(5604):223-6
pubmed: 12522243
Hum Reprod. 2014 Aug;29(8):1618-21
pubmed: 24903203
Oncol Lett. 2016 Jan;11(1):168-172
pubmed: 26870184
Oncotarget. 2017 Aug 24;8(43):74806-74819
pubmed: 29088825
Fertil Steril. 2019 Jun;111(6):1094-1101
pubmed: 31155116
Endocrinology. 2005 Dec;146(12):5313-20
pubmed: 16141390
Int J Mol Sci. 2019 Jan 19;20(2):
pubmed: 30669470
J Reprod Immunol. 2021 Nov;148:103426
pubmed: 34653814
Fertil Steril. 2009 Apr;91(4):1042-9, 1049.e1-9
pubmed: 18355812
Medicine (Baltimore). 2022 Aug 19;101(33):e30150
pubmed: 35984122
Front Oncol. 2021 Apr 15;11:637594
pubmed: 33937039
Cell Rep Med. 2022 Sep 20;3(9):100738
pubmed: 36103879
Mol Hum Reprod. 2010 Apr;16(4):273-85
pubmed: 20008415
Reproduction. 2015 Jan;149(1):75-85
pubmed: 25349438
Curr Opin Obstet Gynecol. 2009 Jun;21(3):236-9
pubmed: 19352180
J Mol Cell Biol. 2017 Jun 1;9(3):220-230
pubmed: 28369529

Auteurs

Iwona Scheliga (I)

Department of OB/GYN and REI (UniKiD), Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine University, 40255 Duesseldorf, Germany.

Dunja M Baston-Buest (DM)

Department of OB/GYN and REI (UniKiD), Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine University, 40255 Duesseldorf, Germany.

Gereon Poschmann (G)

Institute for Molecular Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine University, 40225 Duesseldorf, Germany.

Kai Stuehler (K)

Institute for Molecular Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine University, 40225 Duesseldorf, Germany.
Molecular Proteomics Laboratory, Biomedical Research Centre (BMFZ), Heinrich-Heine-University, Universitätsstrasse 1, 40225 Duesseldorf, Germany.

Jan-Steffen Kruessel (JS)

Department of OB/GYN and REI (UniKiD), Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine University, 40255 Duesseldorf, Germany.

Alexandra P Bielfeld (AP)

Department of OB/GYN and REI (UniKiD), Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine University, 40255 Duesseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH